Baidu
map

CANCER EPIDEM BIOMAR:佩戴胸罩并非导致乳癌发病率增加的原因

2014-09-09 何Jason 医学专业新闻

据发表在Cancer Epidemiology, Biomarkers & Prevention杂志的一项研究证实,女性佩戴胸罩并不增加乳腺癌的患病风险。为明确胸罩与乳腺癌之间的联系,研究人员对不同款式的胸罩、首次佩戴胸罩的时间,以及每日佩戴时间进行了数据采集。结果显示,二者并无显著的联系。本研究的作者,来自华盛顿大学公共卫生学院的博士研究生Lu Chen说:“我们并未发现胸罩与乳腺癌有关

据发表在Cancer Epidemiology, Biomarkers & Prevention杂志的一项研究证实,女性佩戴胸罩并不增加乳腺癌的患病风险。

为明确胸罩与乳腺癌之间的联系,研究人员对不同款式的胸罩、首次佩戴胸罩的时间,以及每日佩戴时间进行了数据采集。结果显示,二者并无显著的联系。

本研究的作者,来自华盛顿大学公共卫生学院的博士研究生Lu Chen说:“我们并未发现胸罩与乳腺癌有关的证据。”

人们此前曾经担心,佩戴胸罩可能阻碍乳腺淋巴液循环和引流,导致有害物质在该处堆积,导致乳腺癌风险增加。甚至有“专家”在书中指出,胸罩与乳腺癌之间“存在联系”。此外,由于发达国家的女性乳腺癌风险较高,佩戴胸罩的比例也高,导致人们对此提出疑问。

在美国癌症学会的资助下,Lu的团队对超过1000名确诊乳癌的女性进行研究,并与469名非乳腺癌患者进行对比。在综合多种因素后,Lu发现二者并无联系。

来自哈佛大学公共卫生学院的Dr. Dimitrios Trichopoulos认为,本研究的结论可靠,女性佩戴胸罩是安全的。他认为,如果有人宣称胸罩影响健康,聪明的女性应该无视。

Trichopoulos说:“网络是充满财富和宝藏的地方,但也有大量垃圾。女性无需再为这个问题感到纠结。”


原始出处:

Chen L1, Malone KE2, Li CI2.Bra Wearing Not Associated with Breast Cancer Risk: A Population-Based Case-Control Study.Cancer Epidemiol Biomarkers Prev. 2014 Sep 5. [Epub ahead of print]’

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2079232, encodeId=3c0720e923226, content=<a href='/topic/show?id=659ce1280ee' target=_blank style='color:#2F92EE;'>#癌发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71280, encryptionId=659ce1280ee, topicName=癌发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jan 01 19:31:00 CST 2015, time=2015-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823220, encodeId=6e921823220a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Feb 05 13:31:00 CST 2015, time=2015-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799796, encodeId=05d61e997967f, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Sat Jun 27 23:31:00 CST 2015, time=2015-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917069, encodeId=d333191e069d3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 07 15:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11620, encodeId=2761116206c, content=什么研究都有哈!话说,这个研究虽然不高大上,但是确实是女性关心的话题哈,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3fd107127, createdName=wutongshulyl, createdTime=Fri Sep 12 22:34:00 CST 2014, time=2014-09-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2079232, encodeId=3c0720e923226, content=<a href='/topic/show?id=659ce1280ee' target=_blank style='color:#2F92EE;'>#癌发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71280, encryptionId=659ce1280ee, topicName=癌发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jan 01 19:31:00 CST 2015, time=2015-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823220, encodeId=6e921823220a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Feb 05 13:31:00 CST 2015, time=2015-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799796, encodeId=05d61e997967f, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Sat Jun 27 23:31:00 CST 2015, time=2015-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917069, encodeId=d333191e069d3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 07 15:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11620, encodeId=2761116206c, content=什么研究都有哈!话说,这个研究虽然不高大上,但是确实是女性关心的话题哈,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3fd107127, createdName=wutongshulyl, createdTime=Fri Sep 12 22:34:00 CST 2014, time=2014-09-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2079232, encodeId=3c0720e923226, content=<a href='/topic/show?id=659ce1280ee' target=_blank style='color:#2F92EE;'>#癌发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71280, encryptionId=659ce1280ee, topicName=癌发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jan 01 19:31:00 CST 2015, time=2015-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823220, encodeId=6e921823220a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Feb 05 13:31:00 CST 2015, time=2015-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799796, encodeId=05d61e997967f, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Sat Jun 27 23:31:00 CST 2015, time=2015-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917069, encodeId=d333191e069d3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 07 15:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11620, encodeId=2761116206c, content=什么研究都有哈!话说,这个研究虽然不高大上,但是确实是女性关心的话题哈,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3fd107127, createdName=wutongshulyl, createdTime=Fri Sep 12 22:34:00 CST 2014, time=2014-09-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2079232, encodeId=3c0720e923226, content=<a href='/topic/show?id=659ce1280ee' target=_blank style='color:#2F92EE;'>#癌发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71280, encryptionId=659ce1280ee, topicName=癌发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jan 01 19:31:00 CST 2015, time=2015-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823220, encodeId=6e921823220a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Feb 05 13:31:00 CST 2015, time=2015-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799796, encodeId=05d61e997967f, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Sat Jun 27 23:31:00 CST 2015, time=2015-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917069, encodeId=d333191e069d3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 07 15:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11620, encodeId=2761116206c, content=什么研究都有哈!话说,这个研究虽然不高大上,但是确实是女性关心的话题哈,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3fd107127, createdName=wutongshulyl, createdTime=Fri Sep 12 22:34:00 CST 2014, time=2014-09-12, status=1, ipAttribution=)]
    2015-02-07 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=2079232, encodeId=3c0720e923226, content=<a href='/topic/show?id=659ce1280ee' target=_blank style='color:#2F92EE;'>#癌发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71280, encryptionId=659ce1280ee, topicName=癌发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Thu Jan 01 19:31:00 CST 2015, time=2015-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823220, encodeId=6e921823220a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Thu Feb 05 13:31:00 CST 2015, time=2015-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799796, encodeId=05d61e997967f, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Sat Jun 27 23:31:00 CST 2015, time=2015-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917069, encodeId=d333191e069d3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 07 15:31:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11620, encodeId=2761116206c, content=什么研究都有哈!话说,这个研究虽然不高大上,但是确实是女性关心的话题哈,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3fd107127, createdName=wutongshulyl, createdTime=Fri Sep 12 22:34:00 CST 2014, time=2014-09-12, status=1, ipAttribution=)]
    2014-09-12 wutongshulyl

    什么研究都有哈!话说,这个研究虽然不高大上,但是确实是女性关心的话题哈,学习了!

    0

相关资讯

PNAS:美发现一种可控制乳腺癌转移的酶

近日,美国加州大学圣地亚哥医学院的研究人员发现并确定了一种酶,这种酶能控制乳腺癌的转移。研究结果发表在最新一期的《美国国家科学院院刊》上,这为全球乳腺癌死亡的主要原因提供新依据。据美国癌症协会估计2014年在美国估计约有40000名妇女将死于乳腺癌。 “这项研究的关键信息是我们发现了一种通过酶调整途径来靶向治疗乳腺癌的方法。”第一作者吴雪峰说,他是加州大学圣地亚哥分校的博士后研究员。这种

JAMA:双侧乳腺切除术可能没有必要

双侧乳腺切除术是否有利于乳腺癌患者的长期生存?存在巨大争议。以往随机对照研究显示,早期乳腺癌采用保乳术加放疗或乳腺切除术,长期生存是相似的。但是,大量资料显示,乳腺切除术,尤其是双侧乳腺切除术逐年增加。双侧乳腺切除术有两个目的,一是为了治疗乳腺癌,二是为了预防对侧乳腺癌。为什么双侧乳腺切除术如此风迷,尚没有合理的解释,有一个重要理由是基因层面的因素。因为BRCA1和BRCA2基因可能与乳腺癌高发有

第五届全球华人乳癌病友组织联盟大会在京举行

2014年8月29日至31日,第五届全球华人乳癌病友组织联盟大会在北京国际会议中心举行。本届大会由北京协和医院协和粉红花园主办,来自美国、台湾、香港和中国大陆等六十余个病友组织共300余名志愿者及医护人员参加了本次会议。 大会开幕式现场 围绕本届“协子之手,和汝同行”的主题,近50位国内外医学专家、组织管理者分享了疾病预防救治和组织运营管理的前沿知识。涵盖了年轻乳癌、患者教育、运动与乳腺癌

镜头下的乳腺癌患者

近日,纽约摄影师大卫?杰伊(David Jay)发布了一组震撼人心的图片,图片记录了乳腺癌患者术后重生的影像,同时向人们展示了她们与疾病抗争的勇敢与自信。全球乳腺癌发病率自上世纪70年代末一直呈上升趋势,中国虽不是乳癌高发国,但近年发病率增长速度高过高发国。 乳腺癌的发病原因尚未完全清楚,但研究发现乳腺癌发病有一定规律。 1、中国肿瘤登记年报显示:女性乳腺癌年龄别发病率0~24岁年龄段

Genome Biology:英开发IntClust系统改善乳腺癌治疗

最近,英国科学家们开发出一种新的工具,可以将乳腺癌分为十种不同的亚型,有望改善这种疾病的治疗效果。相关研究结果发表在2014年8月28日的Genome Biology杂志。 癌症的发生,是因为遗传变化使正常细胞发展为肿瘤。随着对乳腺癌了解的增多,我们知道,这不是一种单一的疾病——引起不同类型癌症的基因突变是不一样的,这就是为什么肿瘤对治疗的反应有差异,为什么它们会以不同的速度生

谭先杰:遗传性乳腺癌和卵巢癌是否要预防性切除

1990年,研究者发现了一种直接与遗传性乳腺癌有关的基因,命名为乳腺癌1号基因,由于说的是乳腺癌(Breast Cancer),于是英文简称BRCA1,它位于人体细胞核的第17号染色体上。1994年,研究者们在第13号染色体上又发现另外一种与乳腺癌有关的基因,称为BRCA2。在此之后,很多情况下都会把两种基因统称BRCA1/2一起讨论。 实际上,BRCA 1/2是两种具有抑制

Baidu
map
Baidu
map
Baidu
map